Etodolac: An overview of a selective COX-2 inhibitor

Inflammopharmacology

Volumn 7, Issue 3, 1999, Pages 269-275

  Jones, R A ^a  

^a Monmouth Pharmaceuticals   (United Kingdom)

Author keywords

COX 2; Etodolac; NSAIDs

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0033456249     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-999-0010-3     Document Type: Review

References (10)

1. J.D. Arnold I. L. Salom A. E. Berger 1985 Comparison of gastrointestinal microbleeding associated with use of etodolac, ibuprofen, indomethacin, and naproxen in normal subjects Curr. Ther. Res. 37 730 738 1:CAS:528:DyaL2MXkvVWnsrc%3D Arnold, J.D., Salom, I. L., Berger, A. E., et al. (1985). Comparison of gastrointestinal microbleeding associated with use of etodolac, ibuprofen, indomethacin, and naproxen in normal subjects, Curr. Ther. Res. 37, 730–738.
2. C. L. Benhamou 1990 Large-scale open trials with etodolac (Lodine) in France: an assessment of safety Rheumatol. Int. 10 Suppl. 29 34 2150569 10.1007/BF02274753 Benhamou, C. L. (1990). Large-scale open trials with etodolac (Lodine) in France: an assessment of safety, Rheumatol. Int. 10 (Suppl.), 29–34.
3. S. Kawai S. Nishida M. Kato 1998 Comparison of cyclooxygenase-1 and-2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells Eur. J. Pharmacol. 347 87 94 9650852 10.1016/S0014-2999(98)00078-8 1:CAS:528:DyaK1cXjsVeqtLs%3D Kawai, S., Nishida, S., Kato, M., et al. (1998). Comparison of cyclooxygenase-1 and-2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells, Eur. J. Pharmacol. 347, 87–94.
4. F. Lanza M. F. Rack M. Lynn J. Wolf M. Sanda 1987 An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa J. Rheumatol. 14 338 341 2955117 1:STN:280:BiiB2MvgvFM%3D Lanza, F., Rack, M. F., Lynn, M., Wolf, J. and Sanda, M. (1987). An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa, J. Rheumatol. 14, 338–341.
5. D. H. Neustadt 1997 Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis J. Rheumatol. 24 Suppl. 47 17 22 Neustadt, D. H. (1997). Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis, J. Rheumatol. 24 (Suppl. 47), 17–22.
6. D. Riendeau M. D. Percival S. Boyce 1997 Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor Br. J. Pharmacol. 121 105 117 9146894 10.1038/sj.bjp.0701076 1:CAS:528:DyaK2sXjtFekur0%3D Riendeau, D., Percival, M. D., Boyce, S., et al. (1997a). Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor, Br. J. Pharmacol. 121, 105–117.
7. D. Riendeau S. Charleson W. Cromlish J. A. Mancini E. Wong J. Guay 1997 Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays Can. J. Physiol. Pharmacol. 75 1088 1095 9365818 10.1139/cjpp-75-9-1088 1:CAS:528:DyaK2sXnt1Cku7w%3D Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E. and Guay, J. (1997b). Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays, Can. J. Physiol. Pharmacol. 75, 1088–1095.
8. R. I. Russell 1990 Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins Rheumatol. Int. 10 Suppl. 17 21 2150567 10.1007/BF02274751 Russell, R. I. (1990). Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins, Rheumatol. Int. 10 (Suppl.), 17–21.
9. Singh, G., Terry, R., Ramey, D., Halpern, J. and Brown, W. B. (1997). Comparative GI toxicity of NSAIDs, 19th ILAR Congress Singapore (June 12th).
10. T. D. Warner F. Giuliano I. Vojnovic A. Bukasa J. A. Mitchell J. R. Vane 1999 Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proc. Nat. Acad. Sci. 96 7563 7568 10377455 10.1073/pnas.96.13.7563 1:CAS:528:DyaK1MXltVOqsb0%3D Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A. and Vane, J. R. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc. Nat. Acad. Sci. 96, 7563–7568.